Kamada (KMDA) Price to Earnings (2015 - 2026)
Kamada's (KMDA) quarterly Price to Earnings came in at 38.09 in Q2 2026, down 64.7% on a YoY basis from 107.91 in Q2 2025, and down 47.35% quarter-over-quarter from 72.35 in Q1 2026.
Analysis
Kamada (KMDA) Price to Earnings (2015 - 2026) Analysis & Trends
Kamada (KMDA) has reported Price to Earnings for 12 consecutive years, with 38.09 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to Earnings fell 64.7% year-over-year to 38.09; the trailing twelve-month figure through Jun 2026 stood at 13.61 (down 43.4% YoY), and the FY2025 full-year result was 15.23, down 46.91% from the prior year.
- Price to Earnings slipped to 38.09 in Q2 2026 per KMDA's latest filing, from 72.35 in the prior quarter.
- Across five years, Price to Earnings topped out at 417.45 in Q3 2022 and bottomed at 135.28 in Q1 2022.
- Historically, Price to Earnings has averaged 78.72 across 5 years, with a median of 69.73 in 2023.
- The sharpest annual moves came in 2022 and 2023: Price to Earnings slumped 231.25% in 2022, then jumped 353.28% in 2023.
- Over 5 years, Price to Earnings stood at 61.07 in 2022, then increased by 15.44% to 70.5 in 2023, then jumped by 347.54% to 315.5 in 2024, then tumbled by 78.14% to 68.96 in 2025, then sank by 44.76% to 38.09 in 2026.
- According to Business Quant data, Price to Earnings over the past three periods registered 38.09, 72.35, and 68.96 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.30 Bn | 197.31 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.97 Bn | 177.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.27 Bn | 124.42 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.93 Bn | 74.93 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.53 Bn | 56.35 Bn | 1.37 Bn |
| 6 | Moderna | 54.27 Bn | 49.13 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.46 Bn | 31.15 Bn | 992.69 Mn |
| 8 | Biogen | 31.16 Bn | 29.88 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.08 Bn | 30.08 Bn | 1.16 Mn |
| 10 | Kamada | 473.85 Mn | 403.72 Mn | 22.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.09 |
| Mar 31, 2026 | 72.35 |
| Dec 31, 2025 | 68.96 |
| Sep 30, 2025 | 53.65 |
| Jun 30, 2025 | 107.91 |
| Mar 31, 2025 | 41.04 |
| Dec 31, 2024 | 315.50 |
| Sep 30, 2024 | 76.57 |
| Jun 30, 2024 | 62.63 |
| Mar 31, 2024 | 128.32 |
| Dec 31, 2023 | 70.50 |
| Sep 30, 2023 | 74.28 |
| Jun 30, 2023 | 130.52 |
| Mar 31, 2023 | -115.12 |
| Dec 31, 2022 | 61.07 |
| Sep 30, 2022 | 417.45 |
| Jun 30, 2022 | -51.53 |
| Mar 31, 2022 | -135.28 |
| Dec 31, 2021 | -63.20 |
| Sep 30, 2021 | -280.64 |